Thomas Eastling
Director/Board Member at GNI GROUP LTD.
Profile
Thomas Wilson Eastling's current jobs include being a Director at Shanghai Genomics, Inc. since 2015, Chief Financial Officer, Secretary & Director at Berkeley Advanced Biomaterials, Inc. since 2017, Director at GNI Group Ltd.
since 2013, Non-Executive Director at Continent Pharmaceutical Inc. since 2015, Director at GNI Hong Kong Ltd.
since 2015, Chief Financial Officer & Director at Cullgen, Inc. since 2018, Director at Shanghai GEP Pharmaceuticals, Inc. since 2018, and Non-Independent Director at Gyre Therapeutics, Inc. since 2023.
He is also a Member of the National Association of Corporate Directors.
Mr. Eastling's former jobs include being a Managing Director & Senior Vice President-Japan at Duff & Phelps Credit Rating Co. from 1999 to 2000, Managing Director at Fitch Group, Inc., Director at Catalyst Biosciences, Inc., Independent Director at Kai Wo Asset Management Ltd., and MD-Strategic Planning & Investor Relations at SoftBank Corp.
from 2001 to 2003.
Mr. Eastling obtained a graduate degree from Thunderbird School of Global Management in 1983 and an undergraduate degree from the University of Southern California in 1981.
Thomas Eastling active positions
| Companies | Position | Start |
|---|---|---|
| GNI GROUP LTD. | Director/Board Member | 2013-02-28 |
National Association of Corporate Directors
 National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The National Association of Corporate Directors is a non-profit organization that provides essential resources to help directors strengthen board leadership. The American company was founded by Maryann Bruce and the CEO is Peter R. Gleason. | Corporate Officer/Principal | - |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Director/Board Member | 2018-05-31 |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Director of Finance/CFO | 2018-01-31 |
Berkeley Advanced Biomaterials, Inc.
 Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Berkeley Advanced Biomaterials, Inc. manufactures and distributes calcium-based products. Its products include HAP/TCP, nanocrystals, powder, granules and blocks. The company was incorporated by François Génin in October 1996 and is headquartered in Berkeley, CA. | Director of Finance/CFO | 2017-06-30 |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Director/Board Member | 2015-02-28 |
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Director/Board Member | 2015-02-28 |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Director/Board Member | 2015-02-28 |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Director of Finance/CFO | - |
Former positions of Thomas Eastling
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░ ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░ ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Thomas Eastling
| University of Southern California | Undergraduate Degree |
| Thunderbird School of Global Management | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GNI GROUP LTD. | Health Technology |
| SOFTBANK CORP. | Communications |
| Private companies | 12 |
|---|---|
GNI USA, Inc.
GNI USA, Inc. BiotechnologyHealth Technology GNI USA, Inc. engages in therapeutic pharmaceutical products development and production. The company was founded in 2001 and is headquartered in San Jose, CA. | Health Technology |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services GNI Hong Kong Ltd. engages in property management. The company was founded on July 31, 2013 and is headquartered in Hong Kong. | Commercial Services |
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu. | Health Technology |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | Health Technology |
Berkeley Advanced Biomaterials, Inc.
Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Berkeley Advanced Biomaterials, Inc. manufactures and distributes calcium-based products. Its products include HAP/TCP, nanocrystals, powder, granules and blocks. The company was incorporated by François Génin in October 1996 and is headquartered in Berkeley, CA. | Health Technology |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Cullgen, Inc. operates as a biopharmaceutical company. It develops chemical entities for the treatment of diseases lacking effective therapeutic approaches. The company was founded in 2018 and is headquartered in San Diego, CA. | Health Technology |
Duff & Phelps Credit Rating Co.
 Duff & Phelps Credit Rating Co. Investment ManagersFinance Duff & Phelps Credit Rating Co. issues credit ratings on corporate bonds, preferred stocks, commercial paper, and CDs. The company is headquartered in Chicago, IL. | Finance |
Fitch Group, Inc.
 Fitch Group, Inc. Packaged SoftwareTechnology Services Fitch Group, Inc. engages in the provision of credit ratings, opinions, research, and financial data for credit markets. It offers debt market solutions, corporate strategy and business planning, and custom research. The company was founded on December 13, 2005 and is headquartered in New York, NY. | Technology Services |
| Kai Wo Asset Management Ltd. | |
Shanghai GEP Pharmaceuticals, Inc.
Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shanghai GEP Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
National Association of Corporate Directors
National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The National Association of Corporate Directors is a non-profit organization that provides essential resources to help directors strengthen board leadership. The American company was founded by Maryann Bruce and the CEO is Peter R. Gleason. | Commercial Services |
- Stock Market
- Insiders
- Thomas Eastling
